Abstract
Racial differences in response to treatment of hepatitis C virus (HCV) have been noted in several trials. In this study, we compared the response rate to treatment of Asian patients infected by genotype 3 HCV with non-Asians treated for the same genotype. Sixteen of 38 (42.1%) Asians achieved a sustained virological response (SVR), compared with 41 of 66 (62.1%) Caucasians (P = 0.063). At baseline prior to treatment, Asians had a higher histological fibrosis stage (P = 0.0014), indicating more advanced disease at presentation. In univariable analysis of baseline factors predicting failure to achieve an SVR, Asian ethnicity, fibrosis stage, higher serum aspartate transaminase, bilirubin and alkaline phosphatase, as well as lower white cell count, haemoglobin and platelet count were statistically significant. None of these factors achieved significance in multivariate analysis, possibly because of the relatively small number of patients studied. We have observed an inferior response to treatment of Asian vs Caucasian patients. The poor response probably reflects the more advanced liver disease at baseline observed for Asian British patients.
References
Oct 30, 1998·Journal of Gastroenterology and Hepatology·S KabaG C Farrell
Aug 26, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·K R ReddyT Joh
Jun 9, 2001·The Journal of Infectious Diseases·C L ThioM Carrington
Oct 5, 2001·Lancet·M P MannsJ K Albrecht
Sep 27, 2002·The New England Journal of Medicine·Michael W FriedJian Yu
Oct 24, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Anouk T DevWilliam Sievert
Apr 2, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·George N IoannouKris V Kowdley
Jul 29, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Chun-Tao WaiAnna S-F Lok
Jan 15, 2004·Current Gastroenterology Reports·Jaquelyn Fleckenstein
Mar 5, 2004·Annals of Internal Medicine·Stephanos J HadziyannisUNKNOWN PEGASYS International Study Group
May 7, 2004·The American Journal of Gastroenterology·Richard K SterlingMitchell L Shiffman
Jun 8, 2004·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Anne F CelonaMaurizio Bonacini
Jul 3, 2004·Journal of Clinical Gastroenterology·Paul J GaglioUNKNOWN Infergen Study Group
Jul 28, 2004·The American Journal of Medicine·Matthew J HepburnEric J Lawitz
Mar 4, 2005·The American Journal of Gastroenterology·Samuel Daniel
Jul 11, 2006·Journal of Clinical Gastroenterology·Ned SnyderJohn Petersen
Citations
Feb 3, 2011·Hepatology International·Venessa PattulloDavid K H Wong
Apr 2, 2009·Journal of Gastroenterology and Hepatology·Virginia Knight, William Sievert
Mar 11, 2015·Journal of Clinical and Experimental Hepatology·Pankaj PuriManav Wadhawan
Aug 22, 2007·Medical Mycology·S Arunmozhi BalajeeMary E Brandt
Nov 18, 2015·World Journal of Gastroenterology : WJG·Claire GondeauDominique Larrey
Dec 9, 2010·Journal of Viral Hepatitis·A Lawson, UNKNOWN Trent Hepatitis C Study Group